1. ○Kimura I, Kosugi Y, Wu J, Zahradnik J, Yamasoba D, Butlertanaka E, Tanaka Y, Uriu K, Liu Y, Morizako N, Shirakawa K, Kazuma Y, Nomura R, Horisawa Y, Tokunaga, Ueno T, Takaori-Kondo A, Schreiber G, Arase H, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Motozono C, Saito A, Nakagawa S, Sato K. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance. Cell Reports, 38(2):110218, 2022. DOI: 10.1016/j.celrep.2021.110218
2. Kaku, Y., Kuwata*, T., Zahid, HM., Hashiguchi, T., Noda, T., Kuramoto, N., Biswas, S., Matsumoto, K., Shimizu, M., Kawanami, Y., Shimura, K., Onishi, C., Muramoto, Y., Suzuki, T., Sasaki, J., Nagasaki, Y., Minami, R., Motozono, C., Toyoda, M., Takahashi, H., Kishi, H., Fujii, K., Tatsuke, T., Ikeda, T., Maeda, Y., Ueno, T., Koyanagi, Y., Iwagoe, H., Matsushita, S*. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19. Cell Reports, 36(2):109385, 2021. DOI: 10.1016/j.celrep.2021.109385
3. ○Motozono, C., Toyoda., M, Zahradnik, J., Saito, A., Nasser, H., Tan, TS., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., Yue, Y, Shimizu., R, Ito, J., Torii, S., Yonekawa, A., Shimono, N., Nagasaki, Y., Minami, R., Toya, T., Sekiya, N., Fukuhara, T., Matsuura, Y., Schreiber, G., Genotype to Phenotype Japan (G2P-Japan) Consortium, Ikeda, T*., Nakagawa, S*., Ueno, T*., Sato, K*. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe S1931-3128(21) 00284-5, 2021. DOI: 10.1016/j.chom.2021.06.006
4. ○Lynch, AT., Motozono, C., Foster, AJ., Kodar, K., Dangerfield, EM., Yamasaki, S., Wedlock, DN., Timmer, MSM., Stocker, BL. Trehalose diamide glycolipids augment antigen-specific antibody responses in a Mincle-dependent manner. Bioorg Chem. (5.3) 110:104747, 2021. DOI: 10.1016/j.bioorg.2021.104747